MOS MOSAIC CO
Agricultural Chemicals · NYSE · SEC CIK 1285785 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY0.0%
TTM net income YoY-191.3%
TTM EPS YoY-191.5%
Revenue 3-yr CAGR-7.5%
Net income 3-yr CAGR—
Margins
Gross margin7.4%
Operating margin-5.1%
Net margin-9.4%
FCF margin-6.8%
EBITDA margin4.7%
Returns
ROE-9.3%
ROA-4.6%
ROIC (approx.)-2.9%
Asset turnover0.49x
Leverage & solvency
Liabilities / assets52.5%
Debt / equity0.48x
Current ratio1.50x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.45x
Accruals ratio-6.6%
Payout ratio—
Capex / revenue11.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $12.05B | $11.12B | $13.70B | $19.13B | $12.36B |
| Cost of revenue | $10.15B | $9.61B | $11.49B | $13.37B | $9.16B |
| Gross profit | $1.90B | $1.51B | $2.21B | $5.76B | $3.20B |
| SG&A expense | $533.90M | $496.90M | $500.50M | $498.00M | $430.50M |
| Operating income | $821.50M | $621.50M | $1.34B | $4.79B | $2.47B |
| Interest expense | $241.50M | $230.00M | $189.00M | $168.80M | $194.30M |
| Pretax income | $1.21B | $315.40M | $1.33B | $4.64B | $2.22B |
| Income tax | $639.80M | $186.70M | $177.00M | $1.22B | $597.70M |
| Net income | $540.70M | $174.90M | $1.16B | $3.58B | $1.63B |
| EBITDA | $1.87B | $1.65B | $2.30B | $5.72B | $3.28B |
| EPS (basic) | 1.70 | 0.55 | 3.52 | 10.17 | 4.31 |
| EPS (diluted) | 1.70 | 0.55 | 3.50 | 10.06 | 4.27 |
| Dividends declared per share | 0.88 | 0.85 | 0.85 | 0.60 | 0.30 |
| Weighted avg. shares (diluted) | 318.90M | 320.70M | 333.20M | 356.00M | 381.60M |
| Banking | |||||
| Net interest income | -$187.70M | -$182.80M | -$129.40M | -$137.80M | -$169.10M |
| Balance sheet | |||||
| Cash & equivalents | $276.60M | $305.00M | $348.80M | $754.10M | $786.30M |
| Receivables | $1.08B | $1.11B | $1.27B | $1.70B | $1.53B |
| Inventory | $3.36B | $2.55B | $2.52B | $3.54B | $2.74B |
| Current assets | $5.24B | $4.50B | $4.75B | $6.56B | $5.33B |
| PP&E, net | $13.98B | $13.35B | $13.59B | $12.68B | $12.48B |
| Goodwill | $1.01B | $1.06B | $1.14B | $1.12B | $1.17B |
| Total assets | $24.48B | $22.92B | $23.03B | $23.39B | $22.04B |
| Current liabilities | $3.98B | $4.17B | $3.87B | $5.53B | $4.79B |
| Short-term debt | $43.10M | $847.10M | $399.70M | $224.90M | $302.80M |
| Long-term debt | $4.25B | $3.33B | $3.23B | $2.41B | $3.38B |
| Total debt | $4.29B | $4.18B | $3.63B | $2.64B | $3.69B |
| Total liabilities | $12.25B | $11.31B | $10.60B | $11.19B | $11.29B |
| Shareholders' equity | $12.08B | $11.48B | $12.29B | $12.05B | $10.60B |
| Net debt | $4.02B | $3.87B | $3.28B | $1.88B | $2.90B |
| Shares outstanding | 317.41M | 316.93M | 324.10M | 339.07M | 368.73M |
| Cash flow statement | |||||
| Operating cash flow | $824.80M | $1.30B | $2.41B | $3.94B | $2.19B |
| Capital expenditure | $1.36B | $1.25B | $1.40B | $1.25B | $1.29B |
| Free cash flow | -$534.60M | $47.40M | $1.00B | $2.69B | $898.40M |
| Investing cash flow | -$1.31B | -$1.26B | -$1.32B | -$1.26B | -$1.32B |
| Financing cash flow | $452.00M | -$131.90M | -$1.48B | -$2.68B | -$682.10M |
| Depreciation & amortization | $1.05B | $1.03B | $960.60M | $933.90M | $812.90M |
| Stock-based compensation | $30.70M | $31.80M | $33.00M | $27.90M | $29.50M |
| Dividends paid | $280.40M | $270.70M | $351.60M | $197.70M | $103.70M |
| Share buybacks | $0 | $235.40M | $756.00M | $1.67B | $410.90M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.